News & Updates

Show Multimedia Only
Vonoprazan on par with PPIs in BCQ therapy for H. pylori eradication

Vonoprazan on par with PPIs in BCQ therapy for H. pylori eradication

08 Nov 2024

Vonoprazan-based bismuth-containing quadruple therapy (VBCQ) does better at eradicating Helicobacter pylori (H. pylori) than proton pump inhibitor (PPI)-based BCQ therapy (PBCQ), with similar adverse reactions and compliance, a study has shown.

Vonoprazan on par with PPIs in BCQ therapy for H. pylori eradication

08 Nov 2024
IV iron replacement safe, effective for anemia after variceal bleed in cirrhosis patients

IV iron replacement safe, effective for anemia after variceal bleed in cirrhosis patients

21 Oct 2024

Patients with cirrhosis with iron deficiency anemia after variceal bleed (VB) can rely on the efficacy and safety of intravenous (IV) iron replacement, reports a study.

IV iron replacement safe, effective for anemia after variceal bleed in cirrhosis patients

21 Oct 2024
Depression, anxiety tied to intragastric balloon intolerance, early removal

Depression, anxiety tied to intragastric balloon intolerance, early removal

16 Oct 2024 byStephen Padilla

Intragastric balloons (IGBs) are a less-invasive alternative to metabolic bariatric surgery (MBS) in the treatment of obesity and its complications, but many Asians suffer intolerance and have a higher rate of early balloon removal relative to Caucasians, reports a Singapore study. Moreover, both depression and anxiety are associated with early IGB removal.

Depression, anxiety tied to intragastric balloon intolerance, early removal

16 Oct 2024
Endoscopic ARMS improves symptoms, QOL in GERD

Endoscopic ARMS improves symptoms, QOL in GERD

14 Oct 2024

Patients with gastroesophageal reflux disease (GERD) who underwent endoscopic antireflux mucosectomy (ARMS) see improvements in their symptoms, a reduction of medical therapy, and a better quality of life (QOL), reports a study.

Endoscopic ARMS improves symptoms, QOL in GERD

14 Oct 2024